Authors


Larry Gifford

Latest:

Illuminating the Night: Understanding Parkinson Nighttime Symptoms

Larry Gifford, a patient living with Parkinson Disease and president of the PD Avengers, discussed sleep issues and nighttime symptoms faced by millions of patients with the disease worldwide.


Sudhir Sivakumaran, PhD

Latest:

Identifying Impactful Biomarkers of Alzheimer Disease: Sudhir Sivakumaran, PhD; Klaus Romero, MD, MS, FCP

The duo from the Critical Path Institute detailed the thought process behind evaluating the importance of specific biomarkers and their relation to disability progression in Alzheimer disease.


Robin Brey, MD

Latest:

AUPN Leadership Minute Episode 4: How to Meet With Your Dean

Episode 4 of the AUPN Leadership Minute features Clifton L. Gooch, MD, of the University of South Florida; and Robin Brey, MD, of the University of Texas Health Science Center at San Antonio. [WATCH TIME: 3 minutes]


Brooke Eby

Latest:

Clinical Benefits to Emphasizing Patient Voices in ALS: Brooke Eby

A patient advocate within the ALS community discussed the importance of incorporating patients and their voices into clinical meetings and trial design to ultimately meet treatment goals. [WATCH TIME: 4 minutes]


Larry B. Goldstein, MD

Latest:

AUPN Leadership Minute Episode 26: Creating a Formal Junior Faculty Development Plan

Episode 26 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Larry B. Goldstein, MD, of University of Kentucky Medical Center. [WATCH TIME: 8 minutes]


Gonul Ozay, MD

Latest:

Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.


Albert L. Wright, Jr.

Latest:

AUPN Leadership Minute Episode 10: What Your CEO Wants From You

Episode 10 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University and Robert C. Byrd Health; and Albert L. Wright, Jr., the president and CEO of West Virginia University Health System. [WATCH TIME: 4 minutes]


Zoltan Mari, MD

Latest:

Advice to Physicians for Use of Wearable Devices in PD

Zoltan Mari, MD, shares advice and tips to physicians and patients for the use of wearable devices in PD.


Suzan Khoromi, MD, MHS

Latest:

Cluster Headache: A Clinical Overview

As the most common trigeminal autonomic cephalalgia, this unilateral and severe headache is accompanied by ipsilateral autonomic features and is often challenging to treat.


Darina Petrovsky, PhD, RN

Latest:

CoMPoSER, Developing a Music-Based Sleep App for Patients With Dementia and Caregivers: Darina Petrovsky, PhD, RN

The assistant professor at Duke University School of Nursing talked about a project aimed at developing a music-based mobile app to improve sleep for individuals with dementia and their caregivers. [WATCH TIME: 5 minutes]


Tom Crawford, MD

Latest:

Building a Greater Knowledge on Use of SMA Therapies: Thomas Crawford, MD

The pediatric neurologist at Johns Hopkins Medicine provided commentary on the steps needed to improve treatment optimization in SMA, and the unanswered questions regarding the key biology of the disease.


Mehmood Rashid, MD

Latest:

AUPN Leadership Minute Episode 3: Teaching Millennial Medical Students

Episode 3 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Mehmood Rashid, MD, of University of Toledo. [WATCH TIME: 4 minutes]


Eoin P. Flanagan, MB, BCh

Latest:

Recognizing the Clinical Features of MOGAD for Diagnosis: Eoin P. Flanagan, MB, BCh

The professor of neurology at Mayo Clinic talked about how MOG antibody-associated disease can be diagnosed through specific antibody tests, highlighting its distinct clinical and MRI features. [WATCH TIME: 4 minutes]


Amanda Peltier, MD

Latest:

Integrating Genetics and Transitional Support in Muscular Dystrophy Care: Amanda Peltier, MD

The professor of neurology at Vanderbilt University Medical Center discussed advocating for reinstating personalized resources, expanding genetic testing, and improving transitional care in muscular dystrophy. [WATCH TIME: 5 minutes]


Russell Lebovitz, MD, PhD

Latest:

Detecting Parkinson Disease at Early Stages With Alpha-Synuclein Amplification Assay: Russell Lebovitz, MD, PhD

The CEO and cofounder of Amprion spoke about additional diagnostic uses of the αSyn seed amplification assay and its validation in the Parkinson's Progression Markers Initiative study at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]


Deepak K. Gulati, MD

Latest:

Functionality of Integrating Artificial Intelligence Into Stroke Scales: Deepak K. Gulati, MD

The associate professor of neurology at The Ohio State University Wexner Medical Center provided insight on research assessing the use of a developed artificial intelligence/machine learning tool for automated stroke scale calculation. [WATCH TIME: 6 minutes]


Tina Duong, PhD, PT

Latest:

Holistic Approach to Medicine and Rehabilitation in Physical Therapy: Tina Duong, PhD, PT

The director of clinical outcomes and research development in neurology at Stanford University spoke about the paradigm shift in neuromuscular therapy interventions at the 2023 MDA conference. [WATCH TIME: 5 minutes]


Garey H. Noritz, MD

Latest:

Advice to Community Neurologists Treating SMA

Closing thoughts on advice to community neurologists treating spinal muscular atrophy (SMA).


Kevin Flanigan, MD

Latest:

Advances in Gene Therapy for Neuromuscular Diseases: Kevin Flanigan, MD

The director of the center for gene therapy at Nationwide Children's Hospital talked about the challenges and opportunities of gene therapies for neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 4 minutes]


Aarushi Suneja, MD

Latest:

Nerve Blocks for the Treatment of COVID-19 Headache: Aarushi Suneja, MD

The headache fellow at Cleveland Clinic outlined the design and reasoning for a new study assessing nerve blocks to treat COVID-19 headache.


Jazmyn Muhammad, BS

Latest:

Insights on Gut Bacteria and Cognitive Health from Middle-Aged Adults: Jazmyn Muhammad, BS

The clinical research associate at the University of Texas Health Science Center at San Antonio discussed a study that explores the relationship between cognitive function and gut microbiome structure in middle-aged adults from the Framingham Heart Study cohort. [WATCH TIME: 4 minutes]


Karen Johnson

Latest:

A Mother’s Fight Against Infantile Spasms: The Power of Instinct and Community

This story highlights a mother’s journey through her daughter Addie's diagnosis of Tuberous Sclerosis Complex (TSC), emphasizing the critical need for early diagnosis, parental advocacy, and the strength of community support.


Milena Pavlova, MD

Latest:

Influence of Antiepileptic Medications on Seizure Frequency in Insomnia: Milena Pavlova, MD

At the 2022 AES annual meeting, the associate professor at Harvard Medical School and neurologist at the Brigham and Women's Hospital talked about seizure frequency and insomnia. [WATCH TIME: 2 minutes]


Nick Corriveau-Lecavalier, PhD

Latest:

Implementing New Diagnostic Criteria of Limbic-Predominant Amnestic Neurodegenerative Syndrome in Clinical Practice: Nick Corriveau-Lecavalier, PhD & David T. Jones, MD

A duo of experts from Mayo Clinic discussed how recent developments in clinical criteria for diagnosing limbic-predominant amnestic neurodegenerative syndrome allow for more accurate differentiation from Alzheimer disease. [WATCH TIME: 9 minutes]


Mike Snape, PhD

Latest:

Assessing Phase 2/3 Trial Safety and Efficacy of AMO-02 for Myotonic Dystrophy: Mike Snape, PhD

The chief scientific officer of AMO Pharma discussed results from a recent clinical trial evaluating the safety and efficacy impact of AMO-02 on children and adolescents with congenital myotonic dystrophy. [WATCH TIME: 6 minutes]


Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN

Latest:

Navigating Challenges and Opportunities With AI Adoption in Neurological Practice: Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN

The neurologist at Mass General Hospital discussed adopting AI technologies in neurology practice, emphasizing the importance of addressing equity concerns alongside technological advancements. [WATCH TIME: 5 minutes]


Richard Williamson, MD, FAANS

Latest:

How Robotics Are Revolutionizing the Future of Neurosurgery: Richard Williamson, MD, FAANS

The neurosurgeon at Allegheny Health Network detailed the potential for robotics in neurosurgery over the coming years, and the vast improvements in comfortability during these procedures. [WATCH TIME: 3 minutes]


Michael D. Weiss, MD, FAAN

Latest:

Understanding Zilucoplan’s Positive Impact on Fatigue in Myasthenia Gravis: Michael D. Weiss, MD, FAAN

The director of the neuromuscular diseases division at the University of Washington discussed findings from a new post hoc analysis presented at AANEM 2023 that showed that zilucoplan treatment significantly reduced fatigue in patients with myasthenia gravis. [WATCH TIME: 6 minutes]


Kin Yuen, MD, MS

Latest:

Emerging Treatment Approaches and Medical Devices for Obstructive Sleep Apnea: Kin Yuen, MD, MS

The sleep medicine specialist at the University of California, San Francisco provided perspective on some of the innovative therapeutic strategies in development for patients with obstructive sleep apnea. [WATCH TIME: 5 minutes]


Yahaira Rivera, MBEd

Latest:

Closing the Gaps in Underserved Multiple Sclerosis Communities: Yahaira Rivera, MBEd

The director of Mission Delivery and Program Development for the Multiple Sclerosis Association of America provided perspective on a study presented at CMSC 2024 highlighting factors that play a role in access to resources and healthcare for patients with MS. [WATCH TIME: 3 minutes]

© 2025 MJH Life Sciences

All rights reserved.